Saturday 17 October 2026
Export RMD’s income statement to Excel — free account
ResMed Inc.
RMD Healthcare Medical Instruments & Supplies
ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025. In the quarter to June 2026, revenue grew 8.58%, EPS grew 2.32%, free cash flow fell 21.3% and total debt fell 39.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
238.97
3.26
−1.35%
Follow RMD
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 24.27% | 25.25% | 25.68% | 25.41% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
6 | 7 | 7 | 7 | |
| 17.77% | 18.59% | 19.00% | 18.52% | ||
ROIC |
21.38% | 22.59% | 21.42% | 21.19% | |
Return on Tangible Assets |
43.38% | 46.33% | 47.40% | 49.01% | |
Average Days of Receivables |
66.90 | 65.83 | 66.64 | 62.99 | |
Free Cash Flow per Share |
11.19 | 11.95 | 12.18 | 12.02 | |
Free Cash Flow |
1,628.66 | 1,736.26 | 1,776.59 | 1,756.56 | |
Capital Expenditures |
(177.17) | (153.70) | (137.90) | (126.81) | |
| Other line items | |||||
Cash ROIC |
19.26% | 20.29% | 21.82% | 22.20% | |
Accounts Receivable Turnover |
5.72 | 5.81 | 5.85 | 6.12 | |
Accounts Payable Turnover |
7.50 | 8.58 | 8.97 | 8.13 | |
Inventory Turnover |
2.35 | 2.40 | 2.34 | 2.25 | |
Average Days of Payables |
51.21 | 46.89 | 43.27 | 46.39 | |
Days of Inventory on Hand |
156.80 | 156.47 | 159.34 | 164.48 | |
Tax Rate |
(0.21) | (0.20) | (0.18) | (0.17) | |
Research and Development Expense of Revenue |
6.69% | 6.48% | 6.46% | 6.45% | |
Selling, General and Administrative Expense of Revenue |
19.80% | 19.69% | 19.45% | 19.27% | |
Share Based Compensation of Revenue |
1.85% | 1.84% | 1.83% | 1.76% | |
Interest Coverage |
(37.80) | (54.41) | (78.10) | (119.75) | |
Operating CF/Net income |
1.19 | 1.24 | 1.29 | 1.31 | |
Depreciation/Fixed assets |
0.42 | 0.46 | 0.44 | 0.43 | |
Capex/Depreciation |
(0.73) | (0.58) | (0.56) | (0.53) | |
Revenue per Share |
38.85 | 38.10 | 37.01 | 35.96 | |
Operating CF per Share |
12.41 | 13.00 | 13.13 | 12.88 | |
Capex per Share |
(1.22) | (1.06) | (0.95) | (0.87) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.02 |
Columns are period end dates